Received: 31 May 2020
Accepted: 7 June 2020
First Online: 19 June 2020
Ethics approval and consent to participate
: The Comité de Protection des Personnes Ouest IV-Nantes approved the study on April 4<sup>th</sup>, 2020 (Reference: CPP 39/20_1, file number 20.4.01.46248). We therefore certify that the COVIDornase trial has received ethical approval from the appropriate ethical committee.Inclusion will be feasible after patient approval, next of kin approval or emergency consent procedure (according to French law). Subsequent confirmation of consent will be obtained from the relatives and from the patient as soon as possible.
: Not applicable.
: The authors declare that they have no competing interests.